NOVEL PEPTIDE AND SALTS THEREOF AND PEPTIDE ANTIALLERGIC AGENTS CONTAINING THESE PEPTIDES

摘要

Novel peptide having the primary structure Asp-Ser-Asp-Gly-Lys or pharmaceutically acceptable salts thereof inhibiting histamine release and IgE antibody production in the onset of type I-allergy and is effective in the prevention or therapy of type I-allergies such as bronchial asthma, urticaria and allergic rhinitis.